Although PARP-1 overactivation leads to PARP-1-dependent cell death or parthanatos which is known to contribute to neurodegenerative diseases (Lee et al., 2015; Li et al., 2019), the role of PAPR-1 in ocular hypertension-associated oxidative damage has rarely been reported. Here, PARP1 is linked to neurodegenerative disease.